One shot for two threats? early test of combo Flu/COVID vaccine begins

NCT ID NCT07464314

Not yet recruiting ⭐️ VACCINE ⭐️ Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

Summary

This is an early-stage study to test a new vaccine designed to protect against both seasonal flu and COVID-19 with a single shot. It will involve 225 healthy adults aged 65 to 85. The main goals are to check if the vaccine is safe and to see how well it triggers the body's protective immune response against both viruses.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA, HUMAN+COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.